跳至主要内容
临床试验/NCT03312582
NCT03312582已完成4 期

Efficacy of Locally Delivered 1% Metformin Gel in the Treatment of Peri-implantitis in Type2 Diabetes Mellitus Patients: A Randomized Controlled Clinical Trial

King Saud University0 个研究点目标入组 46 人开始时间: 2015年3月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
46
主要终点
Marginal bone loss

研究概览

简要总结

This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel with manual debridement while the other half will receive a placebo with manual debridement.

详细描述

Metformin is an oral hypoglycemic drug categorized under biguanide and are considered the most efficient agents widely used in the treatment of type 2 diabetes mellitus.The general clinical benefits observed in therapy with MF seem to be greater than expected. They induce osteoblast cells to promote early bone formation through AMP kinase (AMPK) activity. Moreover, in a recent in vitro study, MF facilitated in the proliferation of MG63 osteoblast like cells. Thus, their action in stimulating bone formation has justified their use in the treatment of perimplantitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes mellitus patients.
  • Patients with peri-implantitis

排除标准

  • History of any other systemic diseases
  • Cigarette smokers
  • Smokeless tobacco users
  • Patients who underwent scaling in the last 1 year
  • Patients who took antibiotics in tje past 6 months

研究组 & 干预措施

Manual debridement and 1% metformin gel

Experimental

干预措施: 1% local metformin gel (Drug)

Manual debridement and placebo

Placebo Comparator

干预措施: Placebo (Procedure)

结局指标

主要结局

Marginal bone loss

时间窗: 6 months

Marginal bone loss will be assessed on digital radiographs on calibrated computer screen.

Peri-implant prpbing depth

时间窗: 6 months

Will be measured with UNC-15 periodontal probe from crest of the gingival margin to the base of the peri-implant probing depth.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zohaib Akram

Director, Clinical Research

King Saud University

相似试验

Locally Delivered 1% Metformin Gel in... | 临床试验